Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits

Shock

Volumn 9, Issue 2, 1998, Pages 138-142

  Roback, Mark G ^a   Stack, Anne M ^b   Thompson, Claudette ^c   Brugnara, Carlo ^b   Schwarz, H Peter ^d   Saladino, Richard A ^b  

^a CHILDREN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; FIBRINOGEN; HEMOGLOBIN; PROTEIN C; PROTHROMBIN;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; HEMATOCRIT; LEUKOCYTE COUNT; MENINGOCOCCOSIS; METABOLISM; MORTALITY; RABBIT; SEPTIC SHOCK; SURVIVAL; THROMBOCYTE COUNT; THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXINS; FIBRINOGEN; HEMATOCRIT; HEMOGLOBINS; LEUKOCYTE COUNT; MENINGOCOCCAL INFECTIONS; PLATELET COUNT; PROTEIN C; PROTHROMBIN; RABBITS; SHOCK, SEPTIC; SURVIVAL; THROMBOSIS;

EID: 0031989122     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199802000-00011     Document Type: Article

References (22)

1. Mayer J, Hajek R, Vorlicek J, Tomiska M: Sepsis and septic shock. I. Definitions and pathophysiology. Supportive Care in Cancer 3:106-110, 1995.
2. Shires GT, Barber AE, Illner HP: Current status of resuscitation: Solutions including hypertonic saline. Adv Surg 28:133-170, 1995.
3. Saez-Llorens X, McCracken GH Jr: Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology, and management. J Pediatr 123:497-508, 1993.
4. Parillo JE: Pathogenetic mechanism of septic shock. N Engl J Med 328:1471-1477, 1993.
5. Havens P, Garland J, Brook M, et al: Trends in mortality in children hospitalized with meningococcal infections, 1957-1987. J Infect Dis 8:8-11, 1989.
6. Powars D, Larsen R, Johnson J, et al: Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. Clin Infect Dis 17:254-261, 1993.
7. Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RB Jr: Purpura fulminans in meningococcemia: Association with acquired deficiencies of proteins C and S. N Engl J Med 317:571-572, 1987.
8. Leclerc F, Hazelet J, Jude B, et al: Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases. Intensive Care Med 18:1-4, 1992.
9. Madden RM, Gill JC, Marlar RA: Protein C and protein S levels in two patients with acquired purpura fulminans. Br J Haematol 75:112-117, 1990.
10. Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G: Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 325:1565-1568, 1991.
11. Conard J, Bauer KA, Gruber A, Griffin JH, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD: Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood 82:1159-1164, 1993.
12. Taylor FB, Chang A, Esmon CT, D'Angelo A, Vignano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effect of Escherichia coli infusions in the baboon. J Clin Invest 79:918-925, 1987.
13. Rivard GE, David M, Farrell C, Schwarz HP: Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 126:646-652, 1995.
14. Caputo GL, Baldwin G, Alpert G, Parsonnet J, Gillis ZA, Siber G, Fleisher G: Effect of meningococcal endotoxin in a rabbit model of shock. Circ Shock 36:104-112, 1992.
15. Hubbard AR: Standardization of protein C in plasma: Establishment of an international standard. Thromb Haemost 59:464-467, 1988.
16. Gruber A, Griffin JH: Direct detection of activated protein C blood from human subjects. Blood 79:2340-2348, 1992.
17. Gerson WT, Dicdrman JD, Bovill EG, Golden E: Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: Treatment with protein C concentrate. Pediatrics 91: 418-422, 1993.
18. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen, E: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195-204, 1989.
19. Esmon CT: Inflammation and thrombosis: The impact of inflammation on the protein C anticoagulant pathway. Haematologica 80:S2:49-56, 1995.
20. Esmon CT, Taylor FB, Snow TR: Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 66:160-165, 1991.
21. Dreyfus M, Masterson M, Rivard G, et al: Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost 21:371-381, 1995.
22. Saladino R, Garcia C, Thompson C, et al: Efficacy of a recombinant endotoxin neutralizing protein in rabbits with E. coli sepsis. Circ Shock 42:104-110, 1994.